J Hudson

IGFBP2 is a biomarker for predicting longitudinal deterioration in renal function in type 2 diabetes

Ram Prakash Narayanan, Bo Fu, Adrian Heald et al. · Endocrine Connections · 2012 · 33 citations · Full text

Medicine, Nephrology, Diabetology +16

Insulin-like growth factor-II and insulin-like growth factor binding protein-2 prospectively predict longitudinal elevation of HDL-cholesterol in type 2 diabetes

Ram Prakash Narayanan, Bo Fu, Robert L. Oliver et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2013 · 16 citations

Medicine, Endocrinology, Diabetology +12

Variability in parathyroid hormone assays confounds clinical practice in chronic kidney disease patients

Helen Eddington, J Hudson, Robert L. Oliver et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 2013 · 12 citations

Medicine, Nephrology, Dialysis +14

Atorvastatin administration is associated with dose-related changes in IGF bioavailability

Ram Prakash Narayanan, Matthew Gittins, Kirk Siddals et al. · European Journal of Endocrinology · 2013 · 12 citations

Pharmacy, Pharmacology, Pharmacotherapy +9